Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sejung Hwang, Dae Young Lee, Joo-Youn Cho, Jae-Yong Chung, In-Jin Jang, Kyung-Sang Yu & SeungHwan Lee. (2021) Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects. Drug Design, Development and Therapy 15, pages 2375-2384.
Read now
Read now
M S Zastrozhin, V Yu Skryabin, S S Miroshkin, E A Bryun & D A Sychev. (2019) Pharmacogenetics of alcohol addiction: current perspectives. The Application of Clinical Genetics 12, pages 131-140.
Read now
Read now
Cyrille Marvalin, Mireille Denoux, Serge Pérard, Sébastien Roy & Robert Azerad. (2012) Microbial production of phase I and phase II metabolites of midazolam. Xenobiotica 42:3, pages 285-293.
Read now
Read now
Articles from other publishers (18)
Koichiro Adachi, Katsuhiro Ohyama, Yoichi Tanaka, Tasuku Sato, Norie Murayama, Makiko Shimizu, Yoshiro Saito & Hiroshi Yamazaki. (2023) High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database. Drug Metabolism and Pharmacokinetics 49, pages 100486.
Crossref
Crossref
Chen-Chen Wang & Tian Lan. (2022)
Functional Analysis of Wild-Type and 27 CYP3A4 Variants on Dronedarone Metabolism
In vitro
. Current Drug Metabolism 23:7, pages 562-570.
Crossref
Crossref
D. Fernando Estrada, Amit Kumar, Christopher S. Campomizzi & Natalie Jay. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
171
192
.
N. A. Shnayder, E. N. Bochanova, D. V. Dmitrenko & R. F. Nasyrova. (2020) Pharmacogenetics of carbamazepine. Epilepsy and paroxysmal conditions 11:4, pages 364-378.
Crossref
Crossref
VivekKumar Garg, ManojKumar Goyal, Madhu Khullar, Biman Saikia, Bikash Medhi, Ajay Prakash, Nandita Prabhat, Naresh Tandyala, KarthikVinay Mahesh, ParampreetS Kharbanda, Sudesh Prabhakar, Manish Modi, Vivek Lal, Ritu Shree & Julie Sachdeva. (2020) Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy. Indian Journal of Pharmacology 52:5, pages 378.
Crossref
Crossref
Maria Gogou & Evangelos Pavlou. (2019) Efficacy of antiepileptic drugs in the era of pharmacogenomics: A focus on childhood. European Journal of Paediatric Neurology 23:5, pages 674-684.
Crossref
Crossref
Xiao-Yang Zhou, Xiao-Xia Hu, Chen-Chen Wang, Xiang-Ran Lu, Zhe Chen, Qian Liu, Guo-Xin Hu & Jian-Ping Cai. (2019) Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro. Frontiers in Pharmacology 10.
Crossref
Crossref
Masahiro Hiratsuka, Noriyasu Hirasawa, Yoshiteru Oshima, Susumu Kodama, Toshio Miyata, Takashi Dan, Hiroyuki Takatoku, Hideaki Kuribayashi, Ryosuke Nakamura & Yoshiro Saito. (2018) Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese population. Drug Metabolism and Pharmacokinetics 33:3, pages 141-149.
Crossref
Crossref
Peter Hlavica. (2017) Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture. Journal of Inorganic Biochemistry 167, pages 100-115.
Crossref
Crossref
Irina F. SevrioukovaThomas L. Poulos. (2016) Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Proceedings of the National Academy of Sciences 114:3, pages 486-491.
Crossref
Crossref
Ilia G. Denisov, Yelena V. Grinkova, Javier L. Baylon, Emad Tajkhorshid & Stephen G. Sligar. (2015) Mechanism of Drug–Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer. Biochemistry 54:13, pages 2227-2239.
Crossref
Crossref
Christian S. Müller, Tim Knehans, Dmitri R. Davydov, Patricia L. Bounds, Ursula von Mandach, James R. Halpert, Amedeo Caflisch & Willem H. Koppenol. (2015) Concurrent Cooperativity and Substrate Inhibition in the Epoxidation of Carbamazepine by Cytochrome P450 3A4 Active Site Mutants Inspired by Molecular Dynamics Simulations. Biochemistry 54:3, pages 711-721.
Crossref
Crossref
Claudio A. Erratico, Anand K. Deo & Stelvio M. Bandiera. 2015. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450
131
149
.
Irina F. Sevrioukova & Thomas L. Poulos. 2015. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450
83
105
.
Li-Ling Yeap, Kheng-Seang Lim, Ching-Ching Ng, Amy Hui-Ping Khor & Yoke-Lin Lo. (2014) Slow Carbamazepine Clearance in a Nonadherent Malay Woman With Epilepsy and Thyrotoxicosis. Therapeutic Drug Monitoring 36:1, pages 3-9.
Crossref
Crossref
Arthur G. Roberts, Jing Yang, James R. Halpert, Sidney D. Nelson, Kenneth T. Thummel & William M. Atkins. (2011) The Structural Basis for Homotropic and Heterotropic Cooperativity of Midazolam Metabolism by Human Cytochrome P450 3A4. Biochemistry 50:50, pages 10804-10818.
Crossref
Crossref
Caroline F. Thorn, Susan G. Leckband, John Kelsoe, J. Steven Leeder, Daniel J. Müller, Teri E. Klein & Russ B. Altman. (2011) PharmGKB summary. Pharmacogenetics and Genomics 21:12, pages 906-910.
Crossref
Crossref
Keiko Maekawa, Noriko Harakawa, Takuya Yoshimura, Su-Ryang Kim, Yoshiyuki Fujimura, Fumika Aohara, Kimie Sai, Noriko Katori, Masahiro Tohkin, Mikihiko Naito, Ryuichi Hasegawa, Haruhiro Okuda, Jun-ichi Sawada, Takuro Niwa & Yoshiro Saito. (2010)
CYP3A4
*
16
and
CYP3A4
*
18
Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs
. Drug Metabolism and Disposition 38:12, pages 2100-2104.
Crossref
Crossref